Valuation
Is the price right?3/3 inputs reported · High confidence
Close to the peer norm on every measure.
Behind the score
Sector-normalized EBITDA, earnings, and free cash flow yields.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Oct 9, 2026
3/3 inputs reported · High confidence
Close to the peer norm on every measure.
Sector-normalized EBITDA, earnings, and free cash flow yields.
3/3 inputs reported · High confidence
Stronger than most peers on:
Revenue and earnings-per-share growth over one year, and revenue growth over three years.
3/3 inputs reported · High confidence
Stronger than most peers on:
Return on invested capital, operating margin, and return on assets.
2/3 inputs reported · Partial data
Mixed versus peers:
Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
No major changes
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Revenue (12 months) | 10.6B USD | 11.0B USD | +4.3% |
| Net income (12 months) | 3.0B USD | 3.1B USD | +5.4% |
| Operating margin | 30.5% | 31.3% | +0.8 pts |
| Free cash flow (12 months) | 2.8B USD | 3.2B USD | +13.7% |
| Cash | 2.0B USD | 2.8B USD | +37.6% |
| Shares outstanding | 354.2M | 353.3M | −0.2% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Valuations in Medical Instruments & Supplies are near the bottom of their range since Jul 2018.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Gross margin | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% | ▼ 1.5 pts |
| Operating margin | 31.9% | 25.3% | 24.8% | 28.1% | 29.3% | ▲ 1.1 pts |
| Net margin | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% | ▲ 0.6 pts |
| Return on assets (ROA) | 12.6% | 10.2% | 11.6% | 12.4% | 14.0% | ▲ 1.6 pts |
| Return on equity (ROE) | 14.3% | 12.0% | 13.5% | 14.1% | 16.0% | ▲ 1.9 pts |
| Free cash flow margin | 30.6% | 15.4% | 10.5% | 15.6% | 24.7% | ▲ 9.1 pts |
| Current ratio | 5.08× | 4.40× | 4.76× | 4.07× | 4.87× | ▲ 20% |
| Quick ratio | 4.57× | 3.77× | 4.02× | 3.22× | 3.96× | ▲ 23% |
Price history is added with the daily price update and will appear after the next one.